UK Wants Early Access Scheme To Remain ‘Relevant And Attractive’ Following Brexit
Proposals Aim To Reduce Burden Associated With Collecting Real-World Data
Executive Summary
The MHRA has drawn up measures to improve regulatory certainty around the UK’s early patient access scheme while reducing regulatory burden in certain areas of its operation.